Purdue Pharma (United States)

Recent papers from Purdue Pharma (United States)

1. Synthesis of Macrocyclic Structures by Intramolecular Photoclick ReactionJournal of the American Chemical Society · 2026
2. Development of a nalmefene formulation suitable for a community‐use auto‐injectorBritish Journal of Clinical Pharmacology · 2026
3. Design, Synthesis, and Pharmacological Characterization of SubstitutedQuinoxalines as NOP Receptor LigandsCurrent Medicinal Chemistry · 2026
4. Stem Cell-Derived Exosomes in Wound Healing and Skin Regeneration: Emerging Therapeutic Strategies and MechanismsCells · 2026
5. An Exploratory Study of Functional Outcome in Stimulant Treatment of ADHD in AdultsJournal of Attention Disorders · 2026
6. Longitudinal Computed Tomographic Evaluation of Mandibular Bone Morphology Following OnabotulinumtoxinA Treatment of Masseter Muscle Prominence: Results of a 12-Month, Repeat-Treatment, Placebo-Controlled Study in Healthy AdultsAesthetic Surgery Journal · 2026
7. Integrating 3D Printing and Additive Manufacturing into Personalized Medicine for Pharmaceuticals: Opportunities, Limitations, and Future PerspectivesScientia Pharmaceutica · 2025
8. Reversal of Fentanyl-Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene Administered by Auto-Injector Versus Intranasal Naloxone.2025
9. High Drug Loading of Amorphous Solid Dispersion by Hot Melt Extrusion: The Role of Magnesium Aluminometasilicate (Neusilin® US2)Scientia Pharmaceutica · 2025
10. Pharmacologic Treatment of Insomnia Reduces Risk of Return to Alcohol Use in Patients in Recovery From Alcohol Use DisorderJournal of Studies on Alcohol and Drugs · 2025
11. Use of Multiple Naloxone Administrations in the Emergency Department: A Retrospective Claims-Based AnalysisJournal of Emergency Medicine · 2025
12. Nanotechnology-Driven Therapeutics for Liver Cancer: Clinical Applications and Pharmaceutical InsightsAsian Journal of Pharmaceutical and Clinical Research · 2025
13. Time Course of Reversal of Fentanyl‐Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene and Intramuscular and Intranasal NaloxoneThe Journal of Clinical Pharmacology · 2024
14. Constructing a One Health governance architecture: a systematic review and analysis of governance mechanisms for One HealthEuropean Journal of Public Health · 2024
15. A Randomized, Phase 3, Double-Blind, Crossover Comparison of Multilayer, Extended-Release Methylphenidate (PRC-063), and Lisdexamfetamine in the Driving Performance of Young Adults With ADHDJournal of Attention Disorders · 2024
16. The nociceptin/orphanin FQ receptor partial agonist sunobinop promotes non-REM sleep in rodents and patients with insomniaJournal of Clinical Investigation · 2023
17. Twelve Months of Denosumab and/or Alendronate Is Associated With Improved Bone Fatigue Life, Microarchitecture, and Density in Ovariectomized Cynomolgus MonkeysJournal of Bone and Mineral Research · 2022
18. Long-term Use of Wearable Health Technology by Chronic Pain PatientsClinical Journal of Pain · 2022
19. Analysis of Daily Sleep Diary Measures From Multilayer Extended-Release Methylphenidate (PRC-063) Studies in Children and Adults With ADHDJournal of Attention Disorders · 2022
20. In vitro inactivation of SARS-CoV-2 using a povidone-iodine oral rinseBMC Oral Health · 2022